Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in pts with advanced solid tumors

被引：1

作者：

Subbiah, V. ^{[1
]}

Combest, A. ^{[2
]}

Griley-Olsen, J. ^{[3
]}

Sharma, N. ^{[4
]}

Andrews, E. ^{[5
]}

Bobe, I. ^{[6
]}

Balkissoon, J. ^{[7
]}

Camp, A. ^{[8
]}

Masada, A. ^{[9
]}

Reitsma, D. ^{[10
]}

Bazhenova, L. ^{[11
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA

[2] PPD, Global Prod Dev, Wilmington, NC USA

[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Hematol & Oncol, Chapel Hill, NC USA

[4] UH Case Med Ctr, Hematol & Oncol, Cleveland, OH USA

[5] PPD, GPD, Raleigh, NC USA

[6] NanoCarrier, Res, Danville, VA USA

[7] PPD, GPD, San Francisco, CA USA

[8] PPD, Biostat, Austin, TX USA

[9] NanoCarrier, Res & Dev, Tokyo, Japan

[10] PPD, Global Prod Dev, Rockville, MD USA

[11] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

10.1093/annonc/mdw368.41

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

398P

引用

页数：1

共 50 条

[31] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
Costello, Brian A.
Borad, Mitesh J.
Qi, Yingwei
Kim, George P.
Northfelt, Donald W.
Erlichman, Charles
Alberts, Steven R.
INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 710 - 716
[32] A phase Ib/II trial of high-dose (HD) ascorbic acid (AA) plus paclitaxel protein bound (PP) plus cisplatin (C) plus gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (MPC)
Jameson, Gayle S.
Borazanci, Erkut H.
Rabinowitz, Joshua
Ansaldo, Karen
LeGrand, Sarah
Propper, David
Snyder, Courtney
Gordon, Michael
Roe, Denise
Von Hoff, Daniel D.
CANCER RESEARCH, 2019, 79 (24)
[33] A phase Ib/II trial of high dose ascorbic acid (AA) plus paclitaxel protein bound (PP) plus cisplatin (C) plus gemcitabine (G) in patients (pts) with previously untreated metastatic pancreatic cancer (MPC).
Jameson, Gayle S.
Borazanci, Erkut H.
Von Hoff, Daniel D.
Rabinowitz, Joshua D.
Gordon, Michael S.
LeGrand, Sarah D.
Snyder, Courtney
Ansaldo, Karen
Roe, Denise J.
Han, Haiyong
CANCER RESEARCH, 2021, 81 (22) : 12 - 13
[34] Phase I trial of gemcitabine and paclitaxel in advanced solid tumors
Lim, N
Lara, PN
Lau, DHM
Edelman, MJ
Tanaka, M
Al-Jazayrly, G
Houston, J
Lauder, I
Gandara, DR
CANCER INVESTIGATION, 2003, 21 (01) : 7 - 13
[35] Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: A phase II multicenter trial
Lorusso, V
Manzione, L
De Vita, F
Antimi, M
Selvaggi, FP
De Lena, M
JOURNAL OF UROLOGY, 2000, 164 (01): : 53 - 56
[36] A phase Ib trial of ERK inhibition with ulixertinib combined with palbociclib in patients (Pts) with advanced solid tumors.
Raybould, Alison L.
Burgess, Brian
Urban, Clarissa
Naim, Rashid
Lee, Michael Sangmin
McRee, Autumn Jackson
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[37] A phase I study of the combination of gemcitabine (G), vinorelbine (V) and cisplatin (P) in patients (pts) with solid tumors.
Schrijvers, D
Dyck, J
Van den Brande, J
Wilmes, P
Korst, A
Lardon, F
Vermorken, J
ANNALS OF ONCOLOGY, 2000, 11 : 140 - 140
[38] Phase Ib study of afatinib plus standard-dose cetuximab in patients (pts) with advanced solid tumors.
Gazzah, Anas
Boni, Valentina
Soria, Jean-Charles
Holgado, Esther
Even, Caroline
Kaci, Mahmoud Ould
Nazabadioko, Serge
Xue, Wenqiong
Calvo, Emiliano
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[39] Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer
De Lange, SM
van Groeningen, CJ
Kroep, JR
Van Bochove, A
Snijders, JF
Peters, GJ
Pinedo, HM
Giaccone, G
ANNALS OF ONCOLOGY, 2004, 15 (03) : 484 - 488
[40] A prospective, multicenter, phase II trial of albumin-paclitaxel plus cisplatin versus gemcitabine plus cisplatin in first-line treatment of advanced biliary tract tumors.
Yang, Xiao
Zhuang, Liang
Dai, Yuhong
Qiu, Hong
Yuan, Xianglin
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →